First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies-Reference-Cited by-同舟云学术

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies

Published:2012-10-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Naumann-Winter Frauke¹²,Greb Alexander²,Borchmann Peter³,Bohlius Julia⁴,Engert Andreas²³,Schnell Roland²³

Affiliation:

1. Federal Institute for Drugs and Medical Devices (BfArM); Kurt-Georg-Kiesinger-Allee 3 Bonn Germany 53175

2. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

3. University Hospital of Cologne; Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

4. University of Bern; Institute of Social and Preventive Medicine; Finkenhubelweg 11 Bern Switzerland 3012

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004626.pub3/fullpdf

Reference129 articles.

1. Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study;Cavo;Journal of Clinical Oncology,2007

2. Giralt S MD Anderson Study Center A Randomized Phase II Trial of tandem transplantation vs thalidomide/dexamethasone maintenance therapy for patients with multiple myeloma failing to achieve complete remission after intensive induction therapy http://utm-ext01a.mdacc.tmc.edu/dept/prot/clinicaltrialswp.nsf/Index/DM00-196

3. Wilson RL Gray ML Giralt S Barriers to second transplant for multiple myeloma in a randomised autologous tandem trial Biology of Blood and Marrow Transplantation 2003

4. Einsele H Stem Cell Transplantation for MM: Analysis of Prognostic Factors[S9.3] Haematologica 2007 49 http://myeloma.org/pdfs/Kos2007_Einsele.pdf [accessed 22.2.2011]

5. Einsele H Liebisch P Bargou R Meisner C Metzner B Wandt H Single high-dose chemoradiotherapy versus tandem high-dose melphalan followed by autologous stem cell transplantation: preliminary analysis Haematologica 2005 131

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

2. Tandem Autologous Stem Cell Transplantation Improve Outcomes in Multiple Myeloma Patients with high risk factors: A Systematic Review and Meta-Analysis;2023-09-29

3. First-line treatment of multiple myeloma in both transplant and non-transplant candidates;Expert Review of Anticancer Therapy;2023-05-16

4. Role of Stem Cell Transplantation in Multiple Myeloma;Cancers;2021-02-18

5. Multiple myeloma;Journal of Modern Oncology;2021-02-17